‘Pipeline In A Pill’ Or Pipe Dream? US FDA’s April Goal Dates Test Expansion Strategies

 
• By Bridget Silverman
  
Sponsors are hoping approvals will blossom along with the cherry trees. (Shutterstock)

More from US FDA Performance Tracker

More from Pathways & Standards